Vivos Therapeutics, Inc. - VVOS

About Gravity Analytica
Recent News
- 02.25.2025 - Sleep Apnea And Stroke: Is There A Connection?
- 02.24.2025 - Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
- 02.18.2025 - Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET.
- 02.11.2025 - Can Tinnitus Cause Sleep Apnea?
- 02.10.2025 - The Link Between Sleep Apnea And Fertility
- 02.01.2025 - The Importance Of Recognizing Tongue Tie On The Development Of The Upper Jaw
- 01.11.2025 - Positional Therapy For Obstructive Sleep Apnea – Are They Effective?
- 01.02.2025 - What Is The Life Expectancy Of Someone With Sleep Apnea?
- 01.01.2025 - Understanding AHI: The Key To A Better Night’s Sleep
- 12.23.2024 - Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Recent Filings
- 02.14.2025 - 424B5 Prospectus [Rule 424(b)(5)]
- 02.14.2025 - 8-K Current report
- 02.11.2025 - S-3 Registration statement under Securities Act of 1933
- 01.31.2025 - 424B1 Prospectus [Rule 424(b)(1)]
- 01.30.2025 - EFFECT Notice of Effectiveness
- 01.29.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
- 01.22.2025 - S-1 General form for registration of securities under the Securities Act of 1933
- 12.30.2024 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 12.26.2024 - 424B5 Prospectus [Rule 424(b)(5)]
- 12.23.2024 - 8-K Current report